Broadly Neutralizing Antibodies for HIV-1 Prevention or Immunotherapy
Authors:
- 24 November 2016
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 375 (21) , 2019-2021
Abstract
High serum titers of neutralizing antibodies develop in a small fraction of people who become infected with HIV-1. Isolation of such broadly neutralizing antibodies (bNAbs) has led to a new and promising approach to combat HIV-1 infection.Keywords
This publication has 5 references indexed in Scilit:
- HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruptionNature, 2016
- A single injection of anti-HIV-1 antibodies protects against repeated SHIV challengesNature, 2016
- Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117Nature, 2015
- Antibodies in HIV-1 Vaccine Development and TherapyScience, 2013
- A method for identification of HIV gp140 binding memory B cells in human bloodJournal of Immunological Methods, 2009